In patients who are event-free after 3-6 months of DAPT and who are not at high ischaemic risk, what change in antithrombotic therapy…

…and a mineralocorticoid receptor antagonist at target doses. The patient and his family are asking about the potential benefits of an implantable cardioverter-defibrillator (ICD…

…You are discussing the initiation of tafamidis therapy to improve cardiovascular outcomes. Which of the following is the most appropriate counseling to provide regarding the…

…He appears disoriented and his vitals are unstable. An ECG is performed urgently. The patient's ECG is presented below. Which alternatives below are correct…

…SVT. Compared to SVT patients who have underlying cardiovascular disease, which of the following clinical characteristics is most likely to be observed in this patient…

…athlete who wishes to avoid lifelong oral anticoagulation and is inquiring about alternatives to a mechanical heart valve. Which of the following is the most…

…anti-thrombotic agent in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). The primary safety endpoint is the incidence of post-procedural…

…Which of the following intravenous medications has been evaluated for termination of sustained monomorphic VT in patients with coronary artery disease with or without healed…

A patient's ECG shows intermittently non-conducted P waves with a fixed PR interval. What type of AV block does this describe, and what…

…old patient with Covid-19 (Sars-Cov-2) has a slightly irregular rhythm. What is the rhythm and should you be concerned about the q…

A 64 year old male patient with hypertension. ECG is recorded during his annual health screening. He is asymptomatic during the recording. Heart rate 67…

…occassionally the sensation that the heart skips a beat. Clinical examination reveals nothing suspicious and the patient has not experienced any symptoms during the last…